Philipp Luik has been a core member of the Health Care practice at Boston Consulting Group since 2010. His focus is on the global pharmaceutical and medtech industries, including prescription drugs, over-the-counter drugs, and animal health. Philipp works with clients on large scale and digital transformation, strategy development, and commercial topics. 

Philipp’s expertise includes business transformations, new operating models, and org design; next generation commercial models and digital go-to-market transformations; portfolio, business unit and corporate strategies; functional strategies; M&A (sell- and buy-side), pre- and post-merger integration, and due diligence; product launches and market entry strategies; and business model innovation with a focus on digital disruption.

AREAS OF EXPERTISE

  • Portfolio, product, and market entry strategy
  • Business model innovation
  • Organizational design
  • Pharmaceutical product launches
  • Project management office
  • Due diligence, M&A, post-merger integration

EDUCATION

  • PhD, biochemistry, Oxford University
  • Diploma in Management, University of London
  • BSc, molecular biotechnology, Ruprecht-Karls Universitat Heidelberg
Deep Expertise, Broad Experience